During the past decade, Suncoast Clinical Research, Inc. conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 61 clinical trials were completed, i.e. on average, 91% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 36 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Suncoast Clinical Research, Inc." #1 sponsor was "Eli Lilly and Company" with 32 trials, followed by "Pfizer" with 7 trials sponsored, "Bayer" with 5 trials sponsored, "Gilead Sciences" with 5 trials sponsored and "AstraZeneca" with 5 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Suncoast Clinical Research, Inc." #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Novartis" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "Alzheimer's Association" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Suncoast Clinical Research, Inc." are "Rheumatoid Arthritis" (11 trials), "Alzheimer Disease" (8 trials), "Type 2 Diabetes" (8 trials), "Type 2 Diabetes Mellitus" (8 trials) and "Diabetes Mellitus, Type 2" (7 trials). Many other conditions were trialed in "Suncoast Clinical Research, Inc." in a lesser frequency.

Most popular intervention types in "Suncoast Clinical Research, Inc." are "Drug" (105 trials), "Behavioral" (4 trials), "Biological" (4 trials), "Device" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (56 trials), "Insulin Degludec" (7 trials), "Insulin Glargine" (4 trials), "Metformin" (4 trials) and "Baricitinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Suncoast Clinical Research, Inc." are 99 trials for "All" genders and 14 trials for "Female" genders.

Currently, there are NaN active trials in "Suncoast Clinical Research, Inc.". undefined are not yet recruiting, 8 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 82 completed trials in Suncoast Clinical Research, Inc., 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Suncoast Clinical Research, Inc., 0 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 3 trials that are defined as “Not Applicable".